Clinical Lab Equipment & Consumables
Companies supplying clinical laboratory instruments, benchtop equipment, single-use technologies and consumables
Evaluating Growth and Value in Clinical Laboratory Products
This segment of clinical laboratory equipment is distinct from research tools in that they fall under EU IVDR regulations, USA FDA 510(k), China SAMR decrees 47 and 48, Japan PMD Act and their worldwide equivalents.
The key trend underpinning this segment is increased automation and efficiency, amid strong private-equity backed consolidation amongst clinical testing labs in Europe. Private equity winners we have worked with (eg. Sebia, Phadia) typically have the most automated solution on the market. Many have dominant market shares.
We help investors and management teams assess opportunities across this diverse market. Our work spans commercial due diligence, transaction support, and growth strategy. We analyse product categories, customer segments, and purchasing dynamics to test the credibility of business plans and identify where real differentiation exists.
Our lab equipment & consumables leads
Our teams combine market knowledge with scientific and operational insight. We review competitive positioning, benchmark valuation multiples against relevant transactions, and evaluate the sustainability of growth drivers such as consumables pull-through, recurring revenue models, and international expansion. This gives clients a clear, evidence-based view of both upside potential and structural risks.
News & Insights
